MEEDER ASSET MANAGEMENT INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 809443
DUBLIN, OH
Position in REGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$4,708,465
+$522,618 QoQ
Shares Held
6,094
+12.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MEEDER ASSET MANAGEMENT INC holds $7,091,404 across 37 Biotechnology names. REGN ranks #1 (66.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
6,094 | $4,708,465 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,424 | $1,528,950 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
10,392 | $257,305 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
1,838 | $103,828 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
9,759 | $87,928 | |
| 6 | VCEL |
Vericel Corp
|
1,900 | $61,123 | |
| 7 | MNPR |
Monopar Therapeutics
|
637 | $34,901 | |
| 8 | ENTA |
Enanta Pharmaceuticals Inc
|
2,025 | $25,575 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,708,465 | 6,094 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,185,847 | 5,423 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,547,079 | 4,530 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,958,900 | 5,636 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $12,684 | 20 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $21,369 | 30 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $214,452 | 204 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $28,377 | 27 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $231,959 | 241 | Shares | Defined | 2024-05-07 | |
| 2023-06-30 | $11,496 | 16 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,966,199 | 4,827 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,506,438 | 4,860 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,182,815 | 6,072 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,192,881 | 7,093 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $4,527,853 | 6,483 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $9,214,505 | 14,591 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $10,156,732 | 16,783 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $8,499,861 | 15,218 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $8,080,282 | 17,078 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $191,311 | 396 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,700,935 | 4,825 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $2,969,195 | 4,761 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $2,329,139 | 4,770 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||